---

May 27, 2020

AI Company ‘Predictmedix’ Launches COVID-19 Screening Technology for Retailers

Toronto-based artificial intelligence (AI) firm Predictmedix (CSE: PMED; OTCQB: PMEDF) has launched screening technologies that will assist businesses by detecting potential COVID-19 infection and other illnesses. The versatile technology will also be used to scan physical spaces to ensure…

Read full release →

May 20, 2020

Predictmedix Inc. Announces a Major North American Sales Contract With Juiceworks Exhibits

Predictmedix Inc. Announces a Major North American Sales Contract with Juiceworks Exhibits for its COVID-19 Mass Screening Technology TORONTO, ON / ACCESSWIRE / May 20, 2020 / Predictmedix Inc. (PMED.CN) (PMEDF) (“Predictmedix” or the “Company”)…

Read full release →

May 20, 2020

PredictMedix signs large North American contract with Juiceworks Exhibits

PredictMedix (CSE: PMED- OTCQB: PMEDF) CEO Rahul Kushwah joined Steve Darling from Proactive Vancouver to share news the company has agreed to terms on a deal with Juiceworks Exhibits. Juiceworks is a North American company…

Read full release →

May 18, 2020

Predictmedix’s Dr. Kushwah on How AI Technology for Mass Screening of COVID-19 Is Here

“We have developed a technology to screening for COVID-19 and the key is, it is a mass screening technology. The technology works with multispectral imaging and our AI algorithms, which are patent pending and sit…

Read full release →

May 15, 2020

PredictMedix: Pharma Monopoly Meets Tech Growth

Here’s a simple and effective investment strategy: invest in companies that sell products with growing inelastic demand. Let’s unpack what that means. The price elasticity of demand for a product is the degree of responsiveness…

Read full release →